Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
Background Cancers arise from multiple acquired mutations, which presumably occur over many years. Early stages in cancer development might be present years before cancers become clinically apparent. Methods We analyzed data from whole-exome sequencing of DNA in peripheral-blood cells from 12,380...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Language: | en_US |
| Published: |
New England Journal of Medicine
2015
|
| Online Access: | http://hdl.handle.net/1721.1/97546 |
| _version_ | 1826191438058094592 |
|---|---|
| author | Genovese, Giulio Kahler, Anna K. Handsaker, Robert E. Lindberg, Johan Rose, Samuel A. Bakhoum, Samuel F. Chambert, Kimberly Mick, Eran Neale, Benjamin M. Fromer, Menachem Purcell, Shaun M. Svantesson, Oscar Landen, Mikael Hoglund, Martin Lehmann, Soren Gabriel, Stacey B. Moran, Jennifer L. Sullivan, Patrick F. Sklar, Pamela Gronberg, Henrik Hultman, Christina M. McCarroll, Steven A. Lander, Eric Steven |
| author2 | Massachusetts Institute of Technology. Department of Biology |
| author_facet | Massachusetts Institute of Technology. Department of Biology Genovese, Giulio Kahler, Anna K. Handsaker, Robert E. Lindberg, Johan Rose, Samuel A. Bakhoum, Samuel F. Chambert, Kimberly Mick, Eran Neale, Benjamin M. Fromer, Menachem Purcell, Shaun M. Svantesson, Oscar Landen, Mikael Hoglund, Martin Lehmann, Soren Gabriel, Stacey B. Moran, Jennifer L. Sullivan, Patrick F. Sklar, Pamela Gronberg, Henrik Hultman, Christina M. McCarroll, Steven A. Lander, Eric Steven |
| author_sort | Genovese, Giulio |
| collection | MIT |
| description | Background
Cancers arise from multiple acquired mutations, which presumably occur over many years. Early stages in cancer development might be present years before cancers become clinically apparent.
Methods
We analyzed data from whole-exome sequencing of DNA in peripheral-blood cells from 12,380 persons, unselected for cancer or hematologic phenotypes. We identified somatic mutations on the basis of unusual allelic fractions. We used data from Swedish national patient registers to follow health outcomes for 2 to 7 years after DNA sampling.
Results
Clonal hematopoiesis with somatic mutations was observed in 10% of persons older than 65 years of age but in only 1% of those younger than 50 years of age. Detectable clonal expansions most frequently involved somatic mutations in three genes (DNMT3A, ASXL1, and TET2) that have previously been implicated in hematologic cancers. Clonal hematopoiesis was a strong risk factor for subsequent hematologic cancer (hazard ratio, 12.9; 95% confidence interval, 5.8 to 28.7). Approximately 42% of hematologic cancers in this cohort arose in persons who had clonality at the time of DNA sampling, more than 6 months before a first diagnosis of cancer. Analysis of bone marrow–biopsy specimens obtained from two patients at the time of diagnosis of acute myeloid leukemia revealed that their cancers arose from the earlier clones.
Conclusions
Clonal hematopoiesis with somatic mutations is readily detected by means of DNA sequencing, is increasingly common as people age, and is associated with increased risks of hematologic cancer and death. A subset of the genes that are mutated in patients with myeloid cancers is frequently mutated in apparently healthy persons; these mutations may represent characteristic early events in the development of hematologic cancers. (Funded by the National Human Genome Research Institute and others.) |
| first_indexed | 2024-09-23T08:55:51Z |
| format | Article |
| id | mit-1721.1/97546 |
| institution | Massachusetts Institute of Technology |
| language | en_US |
| last_indexed | 2024-09-23T08:55:51Z |
| publishDate | 2015 |
| publisher | New England Journal of Medicine |
| record_format | dspace |
| spelling | mit-1721.1/975462022-09-26T09:15:34Z Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence Genovese, Giulio Kahler, Anna K. Handsaker, Robert E. Lindberg, Johan Rose, Samuel A. Bakhoum, Samuel F. Chambert, Kimberly Mick, Eran Neale, Benjamin M. Fromer, Menachem Purcell, Shaun M. Svantesson, Oscar Landen, Mikael Hoglund, Martin Lehmann, Soren Gabriel, Stacey B. Moran, Jennifer L. Sullivan, Patrick F. Sklar, Pamela Gronberg, Henrik Hultman, Christina M. McCarroll, Steven A. Lander, Eric Steven Massachusetts Institute of Technology. Department of Biology Lander, Eric S. Background Cancers arise from multiple acquired mutations, which presumably occur over many years. Early stages in cancer development might be present years before cancers become clinically apparent. Methods We analyzed data from whole-exome sequencing of DNA in peripheral-blood cells from 12,380 persons, unselected for cancer or hematologic phenotypes. We identified somatic mutations on the basis of unusual allelic fractions. We used data from Swedish national patient registers to follow health outcomes for 2 to 7 years after DNA sampling. Results Clonal hematopoiesis with somatic mutations was observed in 10% of persons older than 65 years of age but in only 1% of those younger than 50 years of age. Detectable clonal expansions most frequently involved somatic mutations in three genes (DNMT3A, ASXL1, and TET2) that have previously been implicated in hematologic cancers. Clonal hematopoiesis was a strong risk factor for subsequent hematologic cancer (hazard ratio, 12.9; 95% confidence interval, 5.8 to 28.7). Approximately 42% of hematologic cancers in this cohort arose in persons who had clonality at the time of DNA sampling, more than 6 months before a first diagnosis of cancer. Analysis of bone marrow–biopsy specimens obtained from two patients at the time of diagnosis of acute myeloid leukemia revealed that their cancers arose from the earlier clones. Conclusions Clonal hematopoiesis with somatic mutations is readily detected by means of DNA sequencing, is increasingly common as people age, and is associated with increased risks of hematologic cancer and death. A subset of the genes that are mutated in patients with myeloid cancers is frequently mutated in apparently healthy persons; these mutations may represent characteristic early events in the development of hematologic cancers. (Funded by the National Human Genome Research Institute and others.) National Human Genome Research Institute (U.S.) (Grant U54 HG003067) National Human Genome Research Institute (U.S.) (Grant R01 HG006855) Stanley Center for Psychiatric Research Alexander and Margaret Stewart Trust National Institute of Mental Health (U.S.) (Grant R01 MH 077139) National Institute of Mental Health (U.S.) (Grant RC2 MH089905) Sylvan C. Herman Foundation 2015-06-29T14:56:51Z 2015-06-29T14:56:51Z 2014-11 Article http://purl.org/eprint/type/JournalArticle 0028-4793 1533-4406 http://hdl.handle.net/1721.1/97546 Genovese, Giulio, Anna K. Kahler, Robert E. Handsaker, Johan Lindberg, Samuel A. Rose, Samuel F. Bakhoum, Kimberly Chambert, et al. “Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence.” N Engl J Med 371, no. 26 (December 25, 2014): 2477–2487. en_US http://dx.doi.org/10.1056/NEJMoa1409405 New England Journal of Medicine Creative Commons Attribution-Noncommercial-Share Alike http://creativecommons.org/licenses/by-nc-sa/4.0/ application/pdf New England Journal of Medicine PMC |
| spellingShingle | Genovese, Giulio Kahler, Anna K. Handsaker, Robert E. Lindberg, Johan Rose, Samuel A. Bakhoum, Samuel F. Chambert, Kimberly Mick, Eran Neale, Benjamin M. Fromer, Menachem Purcell, Shaun M. Svantesson, Oscar Landen, Mikael Hoglund, Martin Lehmann, Soren Gabriel, Stacey B. Moran, Jennifer L. Sullivan, Patrick F. Sklar, Pamela Gronberg, Henrik Hultman, Christina M. McCarroll, Steven A. Lander, Eric Steven Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence |
| title | Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence |
| title_full | Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence |
| title_fullStr | Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence |
| title_full_unstemmed | Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence |
| title_short | Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence |
| title_sort | clonal hematopoiesis and blood cancer risk inferred from blood dna sequence |
| url | http://hdl.handle.net/1721.1/97546 |
| work_keys_str_mv | AT genovesegiulio clonalhematopoiesisandbloodcancerriskinferredfromblooddnasequence AT kahlerannak clonalhematopoiesisandbloodcancerriskinferredfromblooddnasequence AT handsakerroberte clonalhematopoiesisandbloodcancerriskinferredfromblooddnasequence AT lindbergjohan clonalhematopoiesisandbloodcancerriskinferredfromblooddnasequence AT rosesamuela clonalhematopoiesisandbloodcancerriskinferredfromblooddnasequence AT bakhoumsamuelf clonalhematopoiesisandbloodcancerriskinferredfromblooddnasequence AT chambertkimberly clonalhematopoiesisandbloodcancerriskinferredfromblooddnasequence AT mickeran clonalhematopoiesisandbloodcancerriskinferredfromblooddnasequence AT nealebenjaminm clonalhematopoiesisandbloodcancerriskinferredfromblooddnasequence AT fromermenachem clonalhematopoiesisandbloodcancerriskinferredfromblooddnasequence AT purcellshaunm clonalhematopoiesisandbloodcancerriskinferredfromblooddnasequence AT svantessonoscar clonalhematopoiesisandbloodcancerriskinferredfromblooddnasequence AT landenmikael clonalhematopoiesisandbloodcancerriskinferredfromblooddnasequence AT hoglundmartin clonalhematopoiesisandbloodcancerriskinferredfromblooddnasequence AT lehmannsoren clonalhematopoiesisandbloodcancerriskinferredfromblooddnasequence AT gabrielstaceyb clonalhematopoiesisandbloodcancerriskinferredfromblooddnasequence AT moranjenniferl clonalhematopoiesisandbloodcancerriskinferredfromblooddnasequence AT sullivanpatrickf clonalhematopoiesisandbloodcancerriskinferredfromblooddnasequence AT sklarpamela clonalhematopoiesisandbloodcancerriskinferredfromblooddnasequence AT gronberghenrik clonalhematopoiesisandbloodcancerriskinferredfromblooddnasequence AT hultmanchristinam clonalhematopoiesisandbloodcancerriskinferredfromblooddnasequence AT mccarrollstevena clonalhematopoiesisandbloodcancerriskinferredfromblooddnasequence AT landerericsteven clonalhematopoiesisandbloodcancerriskinferredfromblooddnasequence |